Anxiety is a risk factor for cardiovascular disease (CVD) and is associated with neurocognitive outcomes. The effect of anxiety on brain perfusion in a CVD population has yet to be examined, and no study has investigated the interactive effects of anxiety and cerebral perfusion on cognition.
Methods:
A total of 55 older adults with CVD completed the Beck Anxiety Inventory (BAI) and underwent arterial spin labeling to quantify cortical perfusion and thickness. Participants were administered the Mini-Mental State Examination (MMSE) and the Repeatable Battery for the Assessment of Neuropsychological Status.
Results:
Reduced perfusion predicted poorer cognition and decreased cortical thickness. Higher anxiety score predicted worse memory performance and decreased frontal perfusion. Frontal lobe hypoperfusion combined with increased BAI scores exacerbated poorer MMSE performance.
Conclusions:
Higher anxiety may exacerbate the effects of cerebral hypoperfusion on cognitive impairment. Longitudinal studies are needed to confirm our findings and determine whether anxiety treatment improves neurocognitive outcomes in CVD.
NyenhuisDLGorelickPBGeenenEJ. The pattern of neuropsychological deficits in vascular cognitive impairment-no dementia (vascular CIND). Clin Neuropsychol. 2004;18(1):41–49.
4.
UnverzagtFWMcClureLAWadleyVG. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology. 2011;77(19):1729–1736.
5.
CardenasVAReedBChaoLL. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke. 2012;43(11):2865–2870.
6.
PakrasiSO’BrienJT. Emission tomography in dementia. Nucl Med Commun. 2005;26(3):189–196.
7.
AustinBPNairVAMeierTB. Effects of hypoperfusion in Alzheimer’s disease. J Alzheimers Dis. 2011;26(suppl 3):123–133.
8.
de la TorreJC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis. Neurobiol Aging. 2000;21(2):331–342.8.
9.
AloscoMLBrickmanAMSpitznagelMB. Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail. 2013;19(4):E29–E34.
10.
MoserDJPontonLLBMillerIN. Cerebral blood flow and neuropsychology functioning in elderly vascular disease patients. J Clin Exp Neuropsychol. 2012;34(2):220–225.
11.
de la TorreJC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol. 2012;2012:367516.
12.
HothKF. Heart failure and cognitive function. In: CohenRAGunstadJ, eds. Neuropsychology and Cardiovascular Disease. Oxford, NY: Oxford University Press; 2010.
13.
Levy-CoopermanNBurhanAMRafi-TariS. Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease. J Psychiatry Neurosci. 2008;33(3):218–226.
14.
DirekNKoudstaalPJHofmanIkramMAHoogendijkWJTiemeierH. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry. 212;72(4):318–323.
15.
AloscoMLSpitznagelMBRazN. The interactive effects of cerebral perfusion and depression on cognitive function in older adults with heart failure. Psychosom Med. 2013;75(7):632–639.
16.
Wolitzky TaylorKBCastriottaNLenzeEJStanleyMACraskeMG. Anxiety disorders in older adults: a comprehensive review. Depress Anxiety. 2010;27(2):190–211.
17.
PlayerMSPetersonLE. Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2011;41(4):365–377.
18.
MartensEJde JongePNaBCohenBELettHWhooleyMA. Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Gen Psychiatry. 2010;67(7):750–758.
19.
VogelsRLCScheltensPSchroeder-TankaJMWeinsteinHC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9(5):440–449.
20.
StillmanANRoweKCArndtSMoserDJ. Anxious symptoms and cognitive function in non-demented older adults: an inverse relationship. Int J Geriatr Psychiatry. 2012;27(8):792–798.
21.
VogelsRLOostermanJMvan HartenB. Neuroimaging and correlates of cognitive function among patients with heart failure. Dementa Geriatr Cogn Disord. 2007;24(6):418–423.
22.
AndreescuCGrossJJLenzeE. Altered cerebral blood flow patterns associated with pathologic worry in the elderly. Depress Anxiety. 2011;28(3):202–209.
23.
ZhangHGuoZYangG. Compromised cerebrovascula modulation in chronic anxiety: evidence from cerebral blood flow velocity measured by transcranial Doppler sonographpy. Neurosci Bull. 2012;28(6):723–728.
24.
BeckATEpsteinNBrownGSteerRA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897.
25.
LuhWMWongECBandettiniPAHydeJS. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med. 1999;41(6):1246–1254.
26.
AloscoMLGunstadJJerskeyBA. The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease. Brain Behav. 2013;3(6):626–636.
27.
ZhuDCPennRD. Full-brain T1 mapping through inversion recovery fast spin echo imaging with time-efficient slice ordering. Magn Reson Med. 2005;54(3):725–731.
28.
WrightPJMouginOETotmanJJ. Water proton T1 measurements in brain tissue at 7, 3, and 1.5 T using IR-EPI, IR-TSE, and MPRAGE: results and optimization. MAGMA. 2008;21(1-2):121–130.
29.
StaniszGJOdrobinaEEPunJ. T1, T2 relaxation and magnetization transfer in tissue at 3 T. Magn Reson Med. 2005;54(3):507–512.
30.
AshburnerJ. Computational anatomy with the SPM software. Magn Reson Imag. 2009;27(8):1163–1174.
31.
AshburnerJFristonKJ. Computing average shaped tissue probability templates. Neuroimage. 2008;45(2):333–341.
FischlBSerenoMIDaleAM. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9(2):195–207.
34.
CoxRW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29(3):162–173.
35.
FischlBDaleAM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000;97(20):11050–11055.
36.
FischlBSalatDHBusaE. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341–355.
37.
FischlBvan der KouweADestrieuxC. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14(1):11–22.
38.
DesikanRSSegonneFFischlB. An automated labeling system for subdiving the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968–980.
39.
FolsteinMFFolsteinSEMcHughPR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res. 1975;12(3):189–198.
40.
RandolphCTierneyMCMohrEChaseTN. Repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310–319.
41.
ArnauRMeagherMNorrisMBramsonR. Psychometric evaluation of the Beck depression inventory-II with primary care medical patients. Health Psychol. 2001;20(2):112–119.
42.
BeckATSteerRABrownGK. Beck Depression Inventory. 2nd ed. San Antonio, TX: The Psychological Corporation; 1996.
43.
LangRMBierigMDevereuxRB. Chamber quantification writing group; American society of echocardiography’s guidelines and standards committee; European association of echocardiography. J Am Soc Echocardiogr. 2005;18(12):1440–1463.
MorenMGDavisASBinkmanJJDeanRS. Neuropsychological measures and single photon emission tomographyin the differentiation and classification of cerebral perfusion deficits in Alzheimer’s dementia. In J Neurosci. 2005;115(8):1131–1149.
46.
QuerbesOAubryFParienteJ. Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain. 2009;132(pt 8):2036–2047.
47.
BurtonCCampbellPJordanKStraussVMallenC. The association of anxiety and depression with future dementia diagnosis: a case–control study in primary care. Fam Prac. 2013;30(1):25–30.
48.
QiuCWinbladBFratiglioniL. Cerebrovascular disease, APOE epsilo4 allele and cognitive decline in a cognitively normal population. NeurolRes. 2006;28(6):650–656.
49.
AloscoMLSpitznagelMBvan DulmenM. Cognitive function and treatment adherence in older adults with heart failure. Psychosom Med. 2012;74(9):965–973.
50.
De JongMJChungMLWuJRRiegelBRayensMKMoserDK. Linkages between anxiety and outcomes in heart failure. Heart Lung. 2011;40(5):393–404.
51.
ZuccalaGPedoneCCesariM. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med. 2003;115(2):97–103.
52.
WilliamsJBAlexanderKPMorinJF. Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol. 2013;111(1):137–142.
53.
WaltersKRaitGPetersenIWilliamsRNazarethI. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice research database. Eur Heart J. 2008;29(24):2981–2988.
54.
ChenYHTsaiSYLeeHCLinHC. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med. 2009;71(7):798–804.
55.
TullyPJCoshSMBauneBT. A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease. Psychol Health Med. 2013;18(6):627–644.
56.
WaldsteinSRBrownJRMaierKJKatzelLI. Diagnosis of hypertension and high blood pressure levels negatively affect cognitive function in older adults. Ann Behav Med. 2005;29(3):174–180.
57.
AlmeidaOPGarridoGJBeerC. Coronary heart disease is associated with regional grey matter volume loss: implications for cognitive function and behaviour. Intern Med J. 2008;38(7):599–606.
58.
SapolskyRM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57(10):925–935.
59.
De QuervainDJHenkeKAerniA. Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci. 2003;17(6):1296–1302.
60.
YangLYangYHeSY. Use of transcranial Doppler sonography to evaluate patients with anxiety disorders before and after treatment. Chin J Lab Diagn. 2012;16:1324–1325.
61.
MontiDAKashKMKunkelEJ. Changes in cerebral blood flow and anxiety associated with an 8-week mindfulness programme in women with breast cancer. Stress Health. 2012;28(5):397–407.
62.
SpencerRJWendellCRGiggeyP. Psychometric limitations of the Mini-Mental State Examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates. Exp Aging Res. 2013;39(4):382–397.
63.
CislerJMOlatunjiBOFeldnerMTFosythJP. Emotion regulation and the anxiety disorders: an integrative review. J Psychopathol Behav Assess. 2010;32(1):68–82.
64.
EtkinAPraterKEHoeftFMenonVSchatzbergAF. Failure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder. Am J Psychiatry. 2010;167(5):545–554.
65.
StussDBensonD. The Frontal Lobes. New York: Raven Press; 1986.
66.
KolbBTaylorL. Neocortical substrates of emotional behavior. In: SteinNLeventhalB, ed. Psychological and Biological Approaches to Emotion. Hillsdale, NJ: Erlbaum; 1990:115–144.
67.
TuckerDMLuuPPribramKH. Social and emotional self-regulation. Ann N Y Acad Sci. 1995;769:213–239.
68.
BijankiKRStillmanANArndtS. White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis. Int J Geriatr Psychiatry. 2013;28(10):1069–1076.
69.
RollsETHornakJWadeDMcGrathJ. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry. 1994;57(12):1518–1524.
70.
BerlowYAWellsWMEllisonJM. Neuropsychiatric correlates of white matter hyperintensities in Alzheimer’s disease. Int J Geriatr Psychiatry. 2010;25(8):780–788.
